A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501

Phase 4 Completed 47 enrolled Pacira Pharmaceuticals, Inc Registrat-Mapi · collab

Non-randomizedParallel-groupOpen-labelHealth-services research

Summary

This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.

Timeline

Start: 2012-03
Primary completion: 2012-10
Completion: 2012-10

Publications

Cohen SM, Vogel JD, Marcet JE, Candiotti KA. Liposome bupivacaine for improvement in economic outcomes and opioid burden in GI surgery: IMPROVE Study pooled analysis. J Pain Res. 2014 Jun 24;7:359-66. doi: 10.2147/JPR.S63764. eCollection 2014.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Bupivacaine	Other / unclassified	266 mg	Other
Subject	Morphine	Other / unclassified	—	Intravenous

Indications

No indication recorded.